In Dec. 2004, David H. Murdock purchased the former Cannon Mills site at auction, future home of the…
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA)Â announced it had approved Genentech’s drug Tarceva…
On Nov. 1, 2004, an Oregon Health & Science University (OHSU) research team announced that it was one…
On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
On Sept. 30, 2003, University of Iowa (UI) Microbiology Professor Mark Stinski made the discoveries of CMV promoter…
On Sept. 29, 2004, a team from scientists from the Pacific Northwest National Laboratory and Oregon Health &…
On Sept. 22, 2004, the National Institutes of Health (NIH) opened the Mark O. Hatfield Clinical Research Center,…
On Sept. 14, 2004, researchers at OHSU and OHSU’s Vaccine and Gene Therapy Institute announced a collaboration with…
On Jul. 21, 2004, Project BioShield Act of 2004 was signed by President George W. Bush. The Act…
On Jun. 26, 2004, the 8th and final report of the Immunization Safety Review Committee was issued by…
On Jun. 16, 2004, Portland’s Schnitzer Investment Corp. donated nearly 20 acres of land at the South Willamette…
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
On April 25 known as DNA Day, is a day that commemorates the successful completion of the Human…
On Apr. 19, 2004, Eli Lilly and Company launched Symbyax in the U.S., the first and only Food…
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
On Mar. 11, 2004, The Kavli Foundation announced a $7.5 million award to establish the Kavli Institute of…
On Mar. 19, 2004, University of California, San Diego (UCSD) was awarded $7.5 million to establish The Kavli…
On Mar. 10, 2004, The Kavli Foundation announced a $7.5 million award to establish a Kavli Institute for…
On Mar. 1, 2004, the National incident Management System (NIMS), developed by the Department of Homeland Security (DHS),…
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
In 2004, the U.S. Congress passed the Anabolic Steroid Control Act which enacted a ban on over-the-counter steroid…
In 2004, the FDA published “Innovation or Stagnation? — Challenge and Opportunity on the Critical Path to New…
In 2004, the Emergency Use Authorization (EUA) program was established in 2004, when the Project BioShield Act, among…
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
In 2004, representatives from a cross-section of bioscience enterprises met under the direction of Governor Ruth Ann Minner…
In 2004, the University of Georgia Cancer Center was established, specializing in drug targets, diagnostic tests, cancer vaccines,…